no statement of use filed
on 03 Apr 2023
Last Applicant/ Owned by
Lilly Corporate Center
Indianapolis
IN
46285
Serial Number
90240075 filed on 07th Oct 2020
Registration Number
N/A
Correspondent Address
Bruce W. Longbottom
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"BARICITINIB"
Pharmaceutical preparations comprised of baricitinib for the treatment of coronavirus and infectious diseases "BARICITINIB" The mark consists of stylized word "Baricitinib" with the first four letters "Bari" bolded and two curved lines, bands or streaks, one curving down and one curving up intersecting over the letter "b".
Pharmaceutical preparations comprised of baricitinib for the treatment of coronavirus and infectious diseases
No 90240075
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
26.03.28 -
Miscellaneous designs with overall oval shape, including amoeba-like shapes and irregular ovals
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of stylized word "Baricitinib" with the first four letters "Bari" bolded and two curved lines, bands or streaks, one curving down and one curving up intersecting over the letter "b".
| Status Date | Action Taken |
|---|---|
| 03rd Apr 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 03rd Apr 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 11th Aug 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 09th Aug 2022 | TEAS EXTENSION RECEIVED |
| 09th Aug 2022 | SOU EXTENSION 1 GRANTED |
| 09th Aug 2022 | SOU EXTENSION 1 FILED |
| 01st Mar 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 16th Jan 2022 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| 05th Oct 2021 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 07th Sep 2021 | PUBLISHED FOR OPPOSITION |
